Gabelli Downgrades Assertio Therapeutics (ASRT) to Hold
Tweet Send to a Friend
Gabelli analyst Kevin Kendra downgraded Assertio Therapeutics (NASDAQ: ASRT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE